/주식/CHEK
CHEK

CHEK

USD

Check-Cap Ltd. Ordinary Share

$0.790+0.139 (21.352%)

실시간 가격

Healthcare
Diagnostics & Research
이스라엘

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$0.651

고가

$0.919

저가

$0.651

거래량

0.00M

기업 기본 정보

시가총액

4.6M

산업

Diagnostics & Research

국가

Israel

거래 통계

평균 거래량

0.17M

거래소

NCM

통화

USD

52주 범위

저가 $0.56현재가 $0.790고가 $3.04

AI 분석 리포트

마지막 업데이트: 2025년 4월 25일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

CHEK (Check-Cap Ltd. Ordinary Share): Analyzing Recent Moves & What Might Come Next

Stock Symbol: CHEK Generate Date: 2025-04-25 11:30:19

Alright, let's take a look at what's been happening with Check-Cap Ltd. stock lately and what the data might be telling us.

Recent News Buzz - What's the Vibe?

Honestly, based on the information provided, there isn't any specific news content to dig into right now. So, we can't really gauge the market's sentiment or the general buzz around the company from recent headlines. This means we'll have to rely more heavily on the price action and any technical signals we can spot.

Price Action - What's the Stock Been Doing?

Looking back at the last month or so of trading data, CHEK has seen quite a ride. It started the period trading above the dollar mark, even spiking significantly to over $1.50 back in late February on some really heavy volume. That was a big move!

However, since that spike, the price has generally trended downwards. It spent much of March bouncing around the $0.80 to $0.90 range, but then took another leg down in early April, dropping into the $0.60s. The good news, if you can call it that, is that in the last few trading days shown, the price seems to have stabilized somewhat, hovering just above the $0.65 level. The previous day's close was right around $0.6688.

Compared to the overall trend since that February spike, the recent movement is sideways to slightly recovering from the April dip.

Putting It Together - Potential Outlook & Strategy Ideas

So, what does this mix of recent price history and the AI's analysis suggest?

The AI's recommendation data leans bullish, giving CHEK a "Bullish Momentum" and "Undervalued Gem" tag with a moderate confidence score (68.22). It points to several technical indicators flashing green signals right now, like the price being just above its 20-day moving average, positive momentum indicators (DMI), and a bullish crossover on the MACD. It also notes a low P/E ratio compared to the industry, suggesting potential value.

Putting this together with the price chart, it seems the AI might be interpreting the recent drop into the $0.60s as a potential bottom or a point where these technical signals are starting to emerge, suggesting a possible bounce or upward move from here.

Apparent Near-Term Leaning: Based specifically on the AI's technical read and the recent price stabilization, the situation seems to favor potential buyers looking for a short-term trade. The AI's analysis points to indicators suggesting upward momentum could be building from the current levels.

Potential Entry Consideration: If you were considering a move based on this, the AI suggests potential entry points around $0.64 and $0.67. The current price is right in that sweet spot. This level looks interesting because it aligns with where the stock has recently found some footing after the April decline and where the AI's bullish technical signals are apparently triggering.

Potential Exit/Stop-Loss Consideration: To manage risk, the AI suggests a stop-loss level at $0.60. This is a logical place, as a drop below this might indicate the recent stabilization isn't holding and the downtrend could continue. For taking profits, the AI gives a target of $0.76. This would represent a decent bounce from the current levels and could be a point to consider selling some or all of a position if the upward momentum plays out. Remember, these are just potential levels based on the analysis provided.

Company Context

It's worth remembering that Check-Cap Ltd. is a clinical-stage medical diagnostics company working on a unique capsule-based colon screening technology. This means its stock price can be heavily influenced by news about clinical trials, regulatory approvals, or commercialization efforts – none of which we had specific news on today. Also, the company details show it has a very small market capitalization (under $4 million) and relatively low average trading volume, although there was that one massive volume spike in February. The AI also flags High Volatility, Low Market Correlation, Small Market Cap, and Low Trading Volume as risk factors. These are important points; small, low-volume stocks can make big moves quickly, in either direction, and can be less predictable than larger companies.


Disclaimer: This analysis is based solely on the provided data and AI recommendations as of the generate date. It is intended for informational purposes only and should not be considered financial advice. Stock investing involves significant risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

AI 예측Beta

AI 추천

중립

업데이트 시간: 2025년 4월 28일 오전 10:12

약세중립강세

68.7% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
가치공격적
트레이딩 가이드

진입점

$0.78

익절

$0.87

손절

$0.75

핵심 요소

현재 가격은 $0.79에서 MA(20)보다 6.7% 높습니다.
PDI 51.4이(가) ADX 13.7과 함께 MDI 32.1 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($0.79)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(2,958)의 3.0배로 상당한 매수 관심을 보여줍니다.
MACD 0.0155이(가) 신호선 0.0157 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기